Anandamide-induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor
- 20 July 2001
- journal article
- brain imaging
- Published by Ovid Technologies (Wolters Kluwer Health) in NeuroReport
- Vol. 12 (10), 2131-2136
- https://doi.org/10.1097/00001756-200107200-00018
Abstract
Anandamide (ANA) alters sleep by increasing the amount of time spent in slow wave sleep 2 (SWS2) and rapid eye movement sleep (REMS) at the expense of wakefulness (W) in rats. In this report, we describe a similar effect of ANA when injected itracerebroventricularly (i.c.v.) or into the peduriculopontine tegmental nucleus (PPTg) and the lack of an effect when ANA is administered into the medial preoptic area (MPOA). Furthermore, the i.c.v. or PPTg administration of SR141716A, a CB1 antagonist, or U73122, a PLC inhibitor, 15 min prior to ANA, readily prevents the ANA induced changes in sleep. The present results suggest that a cannabinoid system in the PPTg may be involved in sleep regulation and that the cannabinoid effect is mediated by the CB1 receptor coupled to a PLC second messenger system.Keywords
This publication has 20 references indexed in Scilit:
- The effects of cannabinoids on the brainProgress in Neurobiology, 1999
- Trick or treat from food endocannabinoids?Nature, 1998
- Anandamide modulates sleep and memory in ratsBrain Research, 1998
- EndocannabinoidsEuropean Journal of Pharmacology, 1998
- Control of pain initiation by endogenous cannabinoidsNature, 1998
- Anandamide may mediate sleep inductionNature, 1997
- Cerebrodiene, arachidonylethanolamide, and hybrid structures: potential for interaction with brain cannabinoid receptorsProstaglandins, Leukotrienes & Essential Fatty Acids, 1996
- Anandamide- and Δ9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-1H-Pyrazole-3-carboximide hydrochloride]Biochemical Pharmacology, 1996
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorFEBS Letters, 1994
- Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction.Proceedings of the National Academy of Sciences, 1993